Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results

被引：0

作者：

Mantegazza, Renato ^{[1
]}

Bril, Vera ^{[2
]}

Vu, Tuan ^{[3
]}

Karam, Chafic ^{[4
]}

Peric, Stojan ^{[5
]}

Margania, Temur ^{[6
]}

Murai, Hiroyuki ^{[7
]}

Bilinska, Malgorzata ^{[8
]}

Shakarishvili, Roman ^{[9
]}

Smilowski, Marek ^{[10
]}

Guglietta, Antonio ^{[11
]}

Ulrichts, Peter ^{[11
]}

Vangeneugden, Tony ^{[11
]}

Utsugisawa, Kimiaki ^{[12
]}

Verschuuren, Jan ^{[13
]}

Howard, James ^{[14
]}

机构：

[1] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Iv Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy

[2] Univ Toronto, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada

[3] Univ S Florida, Morsani Coll Med, Neurol, Tampa, FL 33620 USA

[4] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA

[5] Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia

[6] New Hosp, Dept Neurol & Neurorehabil, Tbilisi, Georgia

[7] Int Univ Hlth & Welf, Neurol, Tokyo, Japan

[8] Wroclaw Med Univ, Dept & Clin Neurol, Wroclaw, Poland

[9] Sarajishvili Inst Neurol & Neurosurg, Neurol, Tbilisi, Poland

[10] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland

[11] Argenx, Clin Dev, Ghent, Belgium

[12] Hanamaki Gen Hosp, Neurol, Hanamaki, Japan

[13] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands

[14] Univ N Carolina, Neurol, Chapel Hill, NC 27515 USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷

关键词：

D O I：

10.1016/j.jns.2021.117764

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

117764

引用

页数：1

共 50 条

[41] Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan
Suzuki, Shigeaki
Uzawa, Akiyuki
Nagane, Yuriko
Masuda, Masayuki
Konno, Shingo
Kubota, Tomoya
Samukawa, Makoto
Ishizuchi, Kei
Tokuyasu, Daiki
Handa, Hideo
Yasuda, Manato
Kawaguchi, Naoki
Kimura, Takashi
Suzuki, Yasushi
Sugimoto, Takamichi
Minami, Naoya
Takahashi, Masanori P.
Murai, Hiroyuki
Utsugisawa, Kimiaki
NEUROLOGY-CLINICAL PRACTICE, 2024, 14 (03)
[42] The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis
Tice, Jeffrey A.
Touchette, Daniel R.
Lien, Pei-Wen
Agboola, Foluso
Nikitin, Dmitriy
Pearson, Steven D.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (01): : 119 - 124
[43] A PHASE-3B OPEN-LABEL STUDY TO FURTHER INDIVIDUALIZE EFGARTIGIMOD TREATMENT OPTIONS FOR PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Gwathmey, Kelly
Sahagian, Gregory
Hussain, Yessar
Feinberg, Marc
Habib, Ali
Skripuletz, Thomas
Ruck, Tobias
Brauer, Edward
Gelinas, Deborah
Zhao, Sihui
Bogatyreva, Anna
Mantegazza, Renato
MUSCLE & NERVE, 2022, 66 : S141 - S142
[44] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
Sacca, F.
Cuomo, N.
Russo, C.
Campanile, M.
Puorro, G.
Marsili, A.
Pane, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 569
[45] Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
Sivadasan, Ajith
Bril, Vera
IMMUNOTHERAPY, 2023, 15 (08) : 553 - 563
[46] A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
Pane, Chiara
Di Stefano, Vincenzo
Cuomo, Nunzia
Sarnataro, Alessio
Vinciguerra, Claudia
Bevilacqua, Liliana
Brighina, Filippo
Rini, Nicasio
Puorro, Giorgia
Marsili, Angela
Garibaldi, Matteo
Fionda, Laura
Sacca, Francesco
JOURNAL OF NEUROLOGY, 2024, 271 (09) : 6209 - 6219
[47] Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis
Dewilde, Sarah
Griffiths, Alison
Qi, Cynthia Z.
Phillips, Glenn
Gelinas, Deborah
Brauer, Edward
Mantegazza, Renato
Howard, James F.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 466
[48] MINIMAL SYMPTOM EXPRESSION IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS FROM TREATMENT WITH EFGARTIGIMOD
Howard, James
Bril, Vera
Vu, Tuan
Karam, Chafic
Pasnoor, Mamatha
Muppidi, Srikanth
Peric, Stojan
Murai, Hiroyuki
Guglietta, Antonio
Ulrichts, Peter
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
MUSCLE & NERVE, 2021, 64 : S3 - S4
[49] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
Barnett, Carolina
Nicholson, Katharine
Chen, Yixin
Syed, Sana
Turner, Timothy
Smyth, Brendan
Howard, James F., Jr.
MUSCLE & NERVE, 2022, 66 : S127 - S128
[50] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
Barnett, Carolina
Kaminski, Henry
Benoit, Patrick
Chen, Yixin
Syed, Sana
Turner, Timothy
Smyth, Brendan
Howard, James F., Jr.
MUSCLE & NERVE, 2022, 66 : S47 - S48

← 1 2 3 4 5 →